Serveur d'exploration SRAS - Analysis (2020)

Index « AbsEn.i » - entrée « diseases »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
disease < diseases < disentangle  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 98.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000029 (2020) Yu-Shi Zhang [République populaire de Chine] ; Wei-Hong Cong [République populaire de Chine] ; Jing-Jing Zhang [République populaire de Chine] ; Fei-Fei Guo [République populaire de Chine] ; Hong-Mei Li [République populaire de Chine][Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].
000032 (2020) Ming Niu [République populaire de Chine] ; Rui-Lin Wang [République populaire de Chine] ; Zhong-Xia Wang [République populaire de Chine] ; Ping Zhang [République populaire de Chine] ; Zhao-Fang Bai [République populaire de Chine] ; Jing Jing [République populaire de Chine] ; Yu-Ming Guo [République populaire de Chine] ; Xu Zhao [République populaire de Chine] ; Xiao-Yan Zhan [République populaire de Chine] ; Zi-Teng Zhang [République populaire de Chine] ; Xue-Ai Song [République populaire de Chine] ; En-Qiang Qin [République populaire de Chine] ; Jia-Bo Wang [République populaire de Chine] ; Xiao-He Xiao [République populaire de Chine][Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].
000034 (2020) Y. Shi [République populaire de Chine] ; N. Wang [République populaire de Chine] ; Q M Zou [République populaire de Chine][Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)].
000038 (2020) Peter Kranke ; Stephanie Weibel ; Magdalena Sitter ; Patrick Meybohm ; Thierry Girard[Obstetric Anesthesia During the SARS-CoV-2 Pandemic - a Brief Overview of Published Recommendations for Action by National and International Specialist Societies and Committees].
000039 (2020) Kaijin Xu [République populaire de Chine] ; Hongliu Cai [République populaire de Chine] ; Yihong Shen [République populaire de Chine] ; Qin Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Shaohua Hu [République populaire de Chine] ; Jianping Li [République populaire de Chine] ; Huafen Wang [République populaire de Chine] ; Liang Yu [République populaire de Chine] ; He Huang [République populaire de Chine] ; Yunqing Qiu [République populaire de Chine] ; Guoqing Wei [République populaire de Chine] ; Qiang Fang [République populaire de Chine] ; Jianying Zhou [République populaire de Chine] ; Jifang Sheng [République populaire de Chine] ; Tingbo Liang [République populaire de Chine] ; Lanjuan Li [République populaire de Chine][Management of corona virus disease-19 (COVID-19): the Zhejiang experience].
000040 (2020) X. Wang [République populaire de Chine] ; Y Q Ding [République populaire de Chine][From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment].
000043 (2020) Specialized Committee Of Neurogenetics Neurophysician Branch Of Chinese Medical Doctor Association [République populaire de Chine] ; Hong Jiang ; Beisha Tang[Expert consensus on the management strategy of patients with hereditary ataxia during prevention and control of novel coronavirus pneumonia epidemic].
000047 (2020) Meryem Aktoz ; Hakan Altay ; Emre Aslanger ; Enver Atalar ; Vedat Aytekin ; Ahmet Oytun Baykan ; Cem Barç N ; Nezihi Bar ; Asiye Ayça Boyac ; Yüksel Çavu O Lu ; Ahmet Çelik ; Göksel Çinier ; Muzaffer De Ertekin ; Önder Ergönül ; Mehmet Ertürk ; M Kemal Erol ; Bülent Görenek ; Mustafa Ozan Gürsoy ; Burak Hünük ; Gökhan Kahveci ; Can Yücel Karabay ; Ilg N Karaca ; Meral Kay Kç O Lu ; Muhammed Keskin ; Teoman K L Ç ; Cevat K Rma ; Umut Kocaba ; Serdar Küçüko Lu ; Bülent Mutlu ; Sanem Nalbantgil ; Ertu Rul Okuyan ; Kaan Okyay ; Deniz Kaptan Zen ; Sami Özgül ; Ebru Özpelit ; Bahar Pirat ; Sena Sert ; Ümit Ya Ar Sinan ; Yusuf Ziya Ener ; Ersan Tatl ; Ahmet Lker Tekke In ; Eralp Tutar ; Dilek Ural ; Özlem Y Ld R Mtürk[Consensus Report from Turkish Society of Cardiology: COVID-19 and Cardiovascular Diseases. What cardiologists should know. (25th March 2020)].
000050 (2020) Cai-Xia Yan [République populaire de Chine] ; Jia Li [République populaire de Chine] ; Xin Shen [République populaire de Chine] ; Li Luo [République populaire de Chine] ; Yan Li [République populaire de Chine] ; Ming-Yuan Li [République populaire de Chine][Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019].
000058 (2020) Zi-Wei Ye [Hong Kong] ; Shuofeng Yuan [Hong Kong] ; Kit-San Yuen [Hong Kong] ; Sin-Yee Fung [Hong Kong] ; Chi-Ping Chan [Hong Kong] ; Dong-Yan Jin [Hong Kong]Zoonotic origins of human coronaviruses
000125 (2020) Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan YanThe origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
000129 (2020) Yan-Chao Li [République populaire de Chine] ; Wan-Zhu Bai [République populaire de Chine] ; Tsutomu Hashikawa [Japon]The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
000139 (2020) Jin-Yan Li [République populaire de Chine] ; Zhi You [République populaire de Chine] ; Qiong Wang [République populaire de Chine] ; Zhi-Jian Zhou [République populaire de Chine] ; Ye Qiu [République populaire de Chine] ; Rui Luo [République populaire de Chine] ; Xing-Yi Ge [République populaire de Chine]The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.
000149 (2020) Y J Duan [République populaire de Chine] ; Q. Liu [République populaire de Chine] ; S Q Zhao [République populaire de Chine] ; F. Huang [République populaire de Chine] ; L. Ren [République populaire de Chine] ; L. Liu [République populaire de Chine] ; Y W Zhou [République populaire de Chine]The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 (COVID-19) and Its Research Progress in Forensic Toxicology.
000164 (2020) The Impact and Control of Emerging and Re-Emerging Viral Diseases in the Environment: An African Perspective
000180 (2020) Jean Christophe Lagier [France] ; Philippe Colson [France] ; Hervé Tissot Dupont [France] ; Jérôme Salomon [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Frédérique Gouriet [France] ; Sophie Baron [France] ; Pierre Dudouet [France] ; Rémi Flores [France] ; Lucie Ailhaud [France] ; Philippe Gautret [France] ; Philippe Parola [France] ; Bernard La Scola [France] ; Didier Raoult [France] ; Philippe Brouqui [France]Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?
000184 (2020) Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine]Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19
000188 (2020) Jiabao Xu ; Shizhe Zhao ; Tieshan Teng ; Abualgasim Elgaili Abdalla ; Wan Zhu ; Longxiang Xie ; Yunlong Wang [République populaire de Chine] ; Xiangqian GuoSystematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
000221 (2020) Nicholas Easom [Royaume-Uni] ; Peter Moss [Royaume-Uni] ; Gavin Barlow [Royaume-Uni] ; Anda Samson [Royaume-Uni] ; Thomas Taynton [Royaume-Uni] ; Kate Adams [Royaume-Uni] ; Monica Ivan [Royaume-Uni] ; Phillipa Burns [Royaume-Uni] ; Kavitha Gajee [Royaume-Uni] ; Kirstine Eastick [Royaume-Uni] ; Patrick J. Lillie [Royaume-Uni]Sixty-eight consecutive patients assessed for COVID-19 infection: Experience from a UK Regional infectious diseases Unit.
000227 (2020) J. Matías-Guiu ; U. Gomez-Pinedo ; P. Montero-Escribano ; P. Gomez-Iglesias ; J. Porta-Etessam ; J. A. Matias-GuiuShould we expect neurological symptoms in the SARS-CoV-2 epidemic?☆
000228 (2020) Ambra Di Altobrando [Italie] ; Annalisa Patrizi [Italie] ; Federico Bardazzi [Italie]Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "diseases" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "diseases" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    diseases
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021